Cargando…
Short-term outcomes in patients with branch retinal vein occlusion who received intravitreal aflibercept with or without intravitreal ranibizumab
PURPOSE: The purpose of this study was to determine the short-term outcomes for patients who received intravitreal aflibercept (IVA) with or without intravitreal ranibizumab (IVR) for macular edema (ME) due to branch retinal vein occlusion (BRVO). PATIENTS AND METHODS: Patients received IVA for ME d...
Autores principales: | Sakanishi, Yoshihito, Usui-Ouchi, Ayumi, Tamaki, Kazunori, Mashimo, Keitaro, Ito, Rei, Ebihara, Nobuyuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5422553/ https://www.ncbi.nlm.nih.gov/pubmed/28496301 http://dx.doi.org/10.2147/OPTH.S133594 |
Ejemplares similares
-
Effects of intravitreal injection of ranibizumab and aflibercept for branch retinal vein occlusion on the choroid: a retrospective study
por: Kishishita, Shuta, et al.
Publicado: (2022) -
Subfoveal Choroidal Thickness and Treatment Outcomes of Intravitreal Aflibercept for Branch Retinal Vein Occlusion
por: Sakanishi, Yoshihito, et al.
Publicado: (2021) -
Twelve-month outcomes in patients with retinal vein occlusion treated with low-frequency intravitreal ranibizumab
por: Sakanishi, Yoshihito, et al.
Publicado: (2016) -
Factors Affecting a Short-Term Response to Anti-VEGF Therapy in Diabetic Macular Edema
por: Usui-Ouchi, Ayumi, et al.
Publicado: (2021) -
Comment on: Ranibizumab and aflibercept intravitreal injection for treatment
naïve and refractory macular oedema in branch retinal vein occlusion
por: Elkazza, Sumeia A, et al.
Publicado: (2020)